PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Rolles, B.* ; Chatain, N.* ; Görg, R.* ; Vieri, M.* ; Tillmann-Tröster, N.* ; Bourgeois, M.G.* ; Christen, D.* ; Walter, J.* ; Hillerbrand, A.C.* ; Romine, K.A.* ; Taylor, K.M.* ; Bertram, J.* ; Jost, E.* ; Koschmieder, S.* ; Beier, F.* ; Stahl, M.* ; Brümmendorf, T.H.* ; Rink, L.* ; Wessels, I.

ZIP10 as a potential therapeutic target in acute myeloid leukaemia.

Br. J. Haematol., DOI: 10.1111/bjh.20229 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Acute myeloid leukaemia (AML) is a haematopoietic malignancy that continues to demonstrate lapses in current treatment modalities as evidenced by therapy refractory disease, disease relapse and high rates of lethality. The influence of nutritional factors, including trace elements, on disease development and progression is not yet well understood. We utilized AML cell lines and patient samples to further investigate zinc homeostasis and the dependency of leukaemic cells on zinc. Compared to control individuals, we found significantly increased zinc levels in malignant blasts with concomitant serum hypozincaemia. Increased cellular zinc levels were accompanied by the upregulation of zinc influx transporters such as ZIP6, ZIP9 and ZIP10. Subsequent in vitro experiments showed the importance of zinc for myeloid cell proliferation, survival and block of differentiation. We validated our results with data from the Leukemia Mile (n = 542) and the BeatAML2.0 study (n = 805). Importantly, we identified ZIP10 (as one of the highly upregulated zinc transporters in malignant blasts) which, when targeted, resulted in impaired zinc uptake and decreased malignant cell growth. These findings suggest that therapeutic approaches that target the zinc influx transporter ZIP10 may offer novel means of treatment for patients suffering from AML.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Aml ; Acute Myeloid Leukaemia ; Leukaemia ; Trace Elements ; Zinc
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0007-1048
e-ISSN 1365-2141
Zeitschrift British Journal of Haematology
Verlag Wiley
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Allergy
PSP-Element(e) G-505400-001
DOI 10.1111/bjh.20229
Scopus ID 105009406603
PubMed ID 40583520
Erfassungsdatum 2025-07-11
[➜Korrektur melden]